Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Morton

Surgery New Haven, CT Medical Doctor

NPI 1972638054 CMS profile 44001

310 Cedar St # 229, New Haven, CT 06510

Open in the dashboard

General payments

$970,304

535 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$30,136

4 holdings reported · through program year 2025

Through program year 2025, John Morton of New Haven, CT is reported in the CMS Open Payments database as having received $970,304 across 535 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $30,136 across 4 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $124,451 82
2024 General $148,377 70
2023 General $121,865 92
2022 General $99,425 51
2021 General $129,127 70
2020 General $120,630 55
2019 General $226,428 115
2022 Ownership $30,136 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Morton
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to John Morton were reported at $124,451. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year John Morton Surgery median Middle half National median
2019 $226,428 $253 $82–$1,521 $163
2020 $120,630 $131 $40–$706 $114
2021 $129,127 $168 $50–$904 $132
2022 $99,425 $224 $76–$1,218 $149
2023 $121,865 $253 $82–$1,255 $160
2024 $148,377 $279 $90–$1,381 $164
2025 $124,451 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Novo Nordisk Inc $385,035 178 payments
  2. Novo Nordisk AS $139,638 37 payments
  3. Medical Device Business Services, Inc. $114,041 55 payments
  4. Teleflex LLC $92,440 45 payments
  5. Olympus America Inc. $74,032 71 payments
  6. Olympus Corporation of the Americas $34,456 30 payments
  7. Boehringer Ingelheim Pharmaceuticals, Inc. $31,393 31 payments
  8. Regeneron Pharmaceuticals, Inc. $18,020 12 payments
  9. Olympus Latin America, Inc. $16,598 8 payments
  10. Olympus Corporation $11,728 10 payments
  11. Other $52,922 58 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $479,488 129 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $288,718 87 payments
  3. Travel and Lodging $146,746 174 payments
  4. Education $30,225 18 payments
  5. Acquisitions $13,324 5 payments
  6. Food and Beverage $11,804 122 payments
Products named General payments · program years 2019–2025
  1. Saxenda $206,565 97 payments
  2. Echelon Flex $92,844 40 payments
  3. Titan SGS $45,925 22 payments
  4. Echelon; Endopath $40,970 25 payments
  5. Harmonic $39,843 15 payments
  6. Wegovy $37,383 25 payments
  7. TITAN SGS BAILOUT CHUCK $33,879 17 payments
  8. GASTROINTESTINAL VIDEOSCOPE $23,435 21 payments
  9. 4K Cable 3.0M $23,042 22 payments
  10. EVIS EXERA III COLONOVIDEOSCOPE $19,478 14 payments
  11. Other $277,439 199 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

535 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Connecticut

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record